U.S. Diversified Financial Stock News

NasdaqCM:FCAP
NasdaqCM:FCAPBanks

First Capital (FCAP) Earnings Growth And 33.1% Margins Reinforce Bullish Community Narrative

First Capital (FCAP) closed out FY 2025 with fourth quarter revenue of US$13.1 million and basic EPS of US$1.46, while trailing twelve month totals reached US$49.5 million of revenue and EPS of US$4.89. Over the past few quarters, revenue has ranged from US$10.5 million in Q3 2024 to US$13.1 million in Q4 2025, with quarterly EPS moving from US$0.87 in Q3 2024 to US$1.46 most recently, alongside trailing net income of US$16.4 million. With a net profit margin of 33.1% over the last year...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

The Bull Case For Patria Investments (PAX) Could Change Following Upward Estimates And Fundraising Momentum - Learn Why

In January 2026, Patria Investments hosted its PAX Talks IV call, focusing on “Investing Amidst Ugly Geopolitics” while analysts highlighted its favorable growth profile and upwardly revised earnings estimates. Against a backdrop of rising institutional demand for alternative assets, Patria’s repeated increases to fundraising guidance and strong fee-earning inflows have reinforced confidence in its long-term growth engine. We’ll now examine how Patria’s upward earnings estimate revisions and...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

A Look At Karman Holdings (KRMN) Valuation After Raised 2025 Guidance And Strong 2026 Outlook

Karman Holdings (KRMN) is back in focus after its Karman Space & Defense unit lifted revenue guidance for fiscal 2025 to US$470 million to US$471 million and outlined a new 2026 outlook of US$700 million to US$715 million. See our latest analysis for Karman Holdings. The guidance update lands after a sharp run up, with Karman’s 30 day share price return of 39.55% and year to date share price return of 40.82% suggesting momentum has been building, even though the latest session saw a 3.04%...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

Is CorMedix (CRMD) A Potential Opportunity After Recent Share Price Volatility?

If you are wondering whether CorMedix at around US$7.27 is priced as a bargain or a trap, you are not alone. That is exactly what this valuation focused rundown aims to unpack. The stock has been volatile recently, with a 7.2% gain over the last 7 days, a 42.0% decline over 30 days, and year to date and 1 year returns of 40.2% and 41.5% declines. The 3 year return sits at 68.7% and the 5 year return at a 16.9% decline. Recent trading moves have put CorMedix back on the radar for investors...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rumble Merger With Northern Data Shifts Focus To AI Infrastructure And Valuation

Rumble, listed as NasdaqGM:RUM, plans to merge with Northern Data AG in a deal focused on artificial intelligence and high performance computing. The transaction is expected to bring Northern Data AG's GPU resources and data center assets under Rumble's umbrella. The companies describe the combination as a way to build out cloud services, AI capabilities, and international reach beyond Rumble's current video platform focus. Rumble started as a video hosting and streaming platform, and the...
NYSE:TEL
NYSE:TELElectronic

TE Connectivity Fortunes Align With Record AI And Industrial Growth

TE Connectivity (NYSE:TEL) has been named to Fortune's World's Most Admired Companies list for the ninth consecutive year. The company reported record first quarter sales and orders, supported by demand in AI, industrial automation, and transportation. TE Connectivity, trading at $223.84, operates at the intersection of several high priority technology trends. The stock is up 47.0% over the past year and 101.6% over five years, which reflects meaningful long term shareholder gains. The...
NYSE:PKG
NYSE:PKGPackaging

Is Packaging Corporation of America (PKG) Pricing Reflecting Its Recent DCF Upside Signal

If you are wondering whether Packaging Corporation of America’s current share price lines up with its underlying worth, this article will walk you through the key signals that matter. The stock last closed at US$225.39, with returns of 1.8% over the past week, 7.9% over the last 30 days, 6.8% year to date, and a 3.8% decline over the past year. The 3 year and 5 year returns sit at 77.3% and 94.6% respectively. Recent news coverage has focused on the company as a major player in the US...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Morningstar Launches GenAI 20 Index To Reframe Its Growth Story

Morningstar has launched the PitchBook GenAI 20 Index, a new benchmark focused on leading generative AI companies. The index is designed to track influential GenAI names from their private market phase through public listing. This creates a single measure of exposure to generative AI across both private and public markets. Morningstar, listed as NasdaqGS:MORN, is rolling out this index while its own share price stands at $210.9. The company’s 1 year return is a 35.4% decline, with a 3 year...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

Is It Too Late To Consider Rambus (RMBS) After Its Strong Multi Year Share Price Run

If you are wondering whether Rambus shares still offer value after a strong run, you are not alone. This article is built to walk you through what the current price might be implying. The stock last closed at US$115.31, with returns of 6.8% over 7 days, 22.5% over 30 days, 16.1% year to date and 83.1% over 1 year, and a very large gain over 5 years that is more than 5x the starting point. Recent attention on Rambus has largely centered on its position within the semiconductor and memory...